Our results in the HLA region are consistent with previous GWASs in cervical cancer, where allelic variation has been reported for HLA-DRB1,10, 12, 14, 16HLA-DQA1,12HLA-DQB1,10, 16HLA-DPB1,13HLA-DPB2,13 and HLA-B,16 and both protective and risk haplotypes have been described. This evidence concerns the gene HLA-DRB1 and cervical carcinoma.